Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...
Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...
Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...
Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...
Enhancing network integration and quality through implementation of a general medical oncology tumor board and disease management group.
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...
The epidemiology of known vector-borne pathogens is changing as common vectors move to new locations. Scientists seek novel strategies for mitigating public health risks and healthcare system burdens.
To permanently access this eBook for free, fill out the short form below. Ready to revolutionise your molecular testing for myeloid malignancies? With a constantly expanding list of biomarkers, ...
Join us for a compelling webinar that delves into gastrointestinal pathogen diagnostics and the crucial role of targeted testing options in routine patient care. A Microbiology and Virology Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback